| 1 |
2025 |
Anna Di Spirito, Sahar Balkhi, Veronica Vivona, Lorenzo Mortara. Key immune cells and their crosstalk in the tumor microenvironment of bladder cancer: insights for innovative therapies, Exploration of Targeted Anti-tumor Therapy. 2025; 6: 1002304.
https://doi.org/10.37349/etat.2025.1002304 |
| 2 |
2025 |
Vikrant Rai, Immune Checkpoint Inhibitor Therapy for Prostate Cancer: Present and Future Prospectives, Biomolecules. 2025; 15: 751.
https://doi.org/10.3390/biom15060751 |
| 3 |
2023 |
Natasa Kustrimovic, Raffaella Bombelli, Denisa Baci, Lorenzo Mortara. Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment, International Journal of Molecular Sciences. 2023; 24: 1511.
https://doi.org/10.3390/ijms24021511 |
| 4 |
2024 |
Margarita Zvirble, Zilvinas Survila, Paulius Bosas, Neringa Dobrovolskiene, Agata Mlynska, Gintaras Zaleskis, Jurgita Jursenaite, Dainius Characiejus, Vita Pasukoniene. Prognostic significance of soluble PD-L1 in prostate cancer, Frontiers in Immunology. 2024; 15: 1401097.
https://doi.org/10.3389/fimmu.2024.1401097 |
| 5 |
2025 |
Akram Hoseinzadeh, Seyed-Alireza Esmaeili, Reza Sahebi, Anahita Madani Melak, Mahmoud Mahmoudi, Maliheh Hasannia, Rasoul Baharlou. Fate and long-lasting therapeutic effects of mesenchymal stromal/stem-like cells: mechanistic insights, Stem Cell Research & Therapy. 2025; 16: 33.
https://doi.org/10.1186/s13287-025-04158-z |
| 6 |
2025 |
Duo Zhang, Yu Heng, Qiu-yan Jin, Di Tang, Xiao-ke Zhu, Li-ming Lu, Chun-ping Wu, Lei Tao. Prognostic significance of cytotoxic-T-lymphocytes to immunosuppressive lymphocytes ratio (CIL) in laryngeal squamous cell carcinoma, Cancer Immunology, Immunotherapy. 2025; 74: 157.
https://doi.org/10.1007/s00262-025-04008-0 |
| 7 |
2023 |
Feixiang Yang, Jiawei Li, Qintao Ge, Yuchen Zhang, Meng Zhang, Jun Zhou, Haitao Wang, Juan Du, Shenglin Gao, Chaozhao Liang, Jialin Meng. Non-coding RNAs: Emerging roles in the characterization of immune microenvironment and immunotherapy of prostate cancer, Biochemical Pharmacology. 2023; 214: 115669115669.
https://doi.org/10.1016/j.bcp.2023.115669 |
| 8 |
2025 |
Ngan Nguyen, Ian C. Henrich. Intra- and Extrahepatic Cholangiocarcinomas Display Differing Sensitivities to NK Cell Lysis and Modulate NK Cell Function through Shared and Distinct Pathways, Molecular Cancer Research. 2025; 23: 155.
https://doi.org/10.1158/1541-7786.MCR-24-0299 |
| 9 |
2025 |
Whi-An Kwon, Jae Young Joung. Precision Targeting in Metastatic Prostate Cancer: Molecular Insights to Therapeutic Frontiers, Biomolecules. 2025; 15: 625.
https://doi.org/10.3390/biom15050625 |
| 10 |
2025 |
Kadriia I. Enikeeva, Diana Kh. Gainullina, Polina N. Shmelkova, Yuliya V. Sharifyanova, Elina R. Akramova, Ildar R. Kabirov, Valentin N. Pavlov. Reprogramming the immune response in prostate cancer treatment, Urology reports (St. - Petersburg). 2025; 15: 75.
https://doi.org/10.17816/uroved646326 |
| 11 |
2023 |
O. A. Korovin, A. V. Alyasova, Kh. M. Arioua, D. V. Novikov, N. V. Krasnogorova, V. V. Novikov. Analysis of the IL-10 mRNA level in the peripheral blood of patients with cancer and benign prostatic hyperplasia, Russian Journal of Biotherapy. 2023; 22: 35.
https://doi.org/10.17650/1726-9784-2023-22-4-35-42 |
| 12 |
2024 |
Sandra C. Ordonez-Rubiano, Brayden P. Strohmier, Surbhi Sood, Emily C. Dykhuizen. SWI/SNF chromatin remodelers in prostate cancer progression, Frontiers in Epigenetics and Epigenomics. 2024; 1: 1337345.
https://doi.org/10.3389/freae.2023.1337345 |
